Literature DB >> 16405412

An authentic malignant epithelioid hemangioendothelioma of the thyroid: a case report and review of the literature.

I Hassan1, P Barth, I Celik, S Hoffmann, P Langer, A Ramaswamy, H-J Wagner, M Rothmund, A Zielke.   

Abstract

Hemangioendotheliomas of the thyroid are neoplasms that are rarely encountered in the Alpine region in Europe. The endemic goiter in this iodine-deficient region can be considered as a predisposing factor. We report the second case of an epithelioid hemangioendothelioma (EHE) of the thyroid gland and the first clinical case with malignant behavior. A 73-year-old woman with a long history of multinodular goiter presented with a rapidly growing thyroid mass, free of distant metastases. A total thyroidectomy was performed. Histologically the lesion had characteristic epithelioid and spindle cell proliferation in a background of chondromyxoid stroma. Cytoplasmic vacuolization in the epithelioid and spindle cells were present. Tumor cells were positive for factor VIII-related antigen, MNF116, PAN-ceratin, CD 34, and CD 31 and negative for cytokeratin allowing the diagnosis of EHE. Nine months after the primary resection the tumor locally recurred. A palliative resection was performed in a second operation followed by interferon-alpha therapy. The patient rapidly developed a second local relapse and died 13 months after the diagnosis of an EHE had been made. An improvement of the very poor prognosis of this rare tumor may depend on early tumor diagnosis and surgery combined with a multimodal treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16405412     DOI: 10.1089/thy.2005.15.1377

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

Review 1.  Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma.

Authors:  Augustine Lau; Steve Malangone; Myke Green; Ambuga Badari; Kathryn Clarke; Emad Elquza
Journal:  Ther Adv Med Oncol       Date:  2015-07       Impact factor: 8.168

Review 2.  Angiosarcoma of the thyroid: a case report with review of the literature.

Authors:  Arshpreet Kaur; Mukund S Didolkar; Asha Thomas
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

Review 3.  Diagnostic controversies in vascular proliferations of the thyroid gland.

Authors:  Mauro Papotti; Marisa Arrondini; Veronica Tavaglione; Andrea Veltri; Marco Volante
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

4.  Epithelioid Hemangioendothelioma: a Rare Primary Thyroid Tumor with Confirmation of WWTR1 and CAMTA1 Rearrangements.

Authors:  Akeesha A Shah; N Paul Ohori; Linwah Yip; Christopher Coyne; Cristina R Antonescu; Raja R Seethala
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

5.  Angiosarcoma of the thyroid.

Authors:  Petra Kalitova; Jan Plzak; Roman Kodet; Jaromir Astl
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-21       Impact factor: 2.503

6.  A Case of an Epithelioid Hemangioendothelioma Arising from the Innominate Vein Mimicking Cervical Metastatic Lymphadenopathy.

Authors:  Jason B Brill; Isaac E Schwartz; Lindsey M Prescher; Theodore C Pratt
Journal:  Case Rep Surg       Date:  2016-12-12

7.  Epithelioid hemangioendothelioma of the thyroid: a case report.

Authors:  Mayu Ono; Yoshio Kasuga; Takeshi Uehara; Yoshinao Oda
Journal:  Surg Case Rep       Date:  2017-01-28

8.  Subcutaneous axillary primary epithelioid hemangioendothelioma: report of a rare case.

Authors:  Takayoshi Niwa; Takaaki Konishi; Asako Sasahara; Ayaka Sato; Arisa Morizono; Mayumi Harada; Kotoe Nishioka; Osamu Fukuoka; Naohiro Makise; Yuki Saito; Mizuo Ando; Takako Yoshimoto; Takeshi Shikama; Satoshi Yamashita; Masahiko Tanabe; Yasuyuki Seto
Journal:  Surg Case Rep       Date:  2022-09-09

9.  Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report.

Authors:  Sumit Gaur; Alireza Torabi; Thomas J O'Neill
Journal:  Cancer Biol Med       Date:  2012-06       Impact factor: 4.248

Review 10.  Malignant Vascular Tumors of the Head and Neck-Which Type of Therapy Works Best?

Authors:  Susanne Wiegand; Andreas Dietz; Gunnar Wichmann
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.